Parapapillary Choroidal Microvasculature Predicts Diabetic Retinopathy Progression and Diabetic Macular Edema Development: A Three-Year Prospective Study
Overview
Authors
Affiliations
Purpose: To determine the predictive value of the microcirculation of the optic nerve head by swept-source optical coherence tomography angiography for identifying individuals with high risk of diabetic retinopathy (DR) progression and diabetic macular edema (DME) development.
Design: Prospective observational cohort study.
Methods: A total of 946 patients (1879 eyes) with type 2 diabetes mellitus were recruited who had no DR or mild nonproliferative DR at baseline, and no DME. All subjects underwent 3 × 3 mm swept-source optical coherence tomography angiography centered on the optic nerve head to generate angiograms in 4 layers: radial peripapillary plexus, superficial retinal capillary plexus (SCP), deep retinal capillary plexus, and choriocapillaris (CC). The CC flow deficit percentage (CC FD%), vessel density (VD), and perfusion density (PD) were quantified.
Results: During the 3 consecutive years of follow-up, 312 eyes (16.60%) experienced DR progression and 115 eyes (6.12%) developed DME. The DR progression was related to a lower VD of the SCP (relative risk per standard deviation decrease, 95% confidence interval): 1.30, 1.14-1.48; P < .001), a lower PD of the SCP (1.41, 1.24-1.60; P < .001), a lower VD of the radial peripapillary plexus (1.23, 1.08-1.40; P = .002), and an elevated CC FD% (1.62, 1.40-1.88; P < .001). The DME occurrence was associated with a lower VD of SCP (1.35, 1.09-1.66; P = .005), a lower PD of SCP (1.29, 1.05-1.59; P = .016), and a higher CC FD% (1.29, 1.03-1.61; P < .001). The CC FD% significantly improved the predictive power, with the increase of the C-statistic for DR progression and DME occurrence by 3.83% (P = .002) and 5.24% (P < .001), respectively.
Conclusions: This study provides the first longitudinal evidence suggesting that peripapillary CC FD% can improve the prediction of DR progression and DME development beyond traditional risk factors.
Nowroozzadeh M, Bagheri M Int J Retina Vitreous. 2025; 11(1):10.
PMID: 39891221 PMC: 11786548. DOI: 10.1186/s40942-024-00618-5.
Li Y, Hu X, Guo X, Ye X, Wang D, Zhang J Front Cell Dev Biol. 2024; 12:1459040.
PMID: 39258228 PMC: 11385310. DOI: 10.3389/fcell.2024.1459040.
OCT angiography 2023 update: focus on diabetic retinopathy.
Crincoli E, Sacconi R, Querques L, Querques G Acta Diabetol. 2024; 61(5):533-541.
PMID: 38376579 DOI: 10.1007/s00592-024-02238-9.
Optical Coherence Tomography Angiography as a Diagnostic Tool for Diabetic Retinopathy.
Wijesingha N, Tsai W, Merve Keskin A, Holmes C, Kazantzis D, Chandak S Diagnostics (Basel). 2024; 14(3).
PMID: 38337841 PMC: 10855126. DOI: 10.3390/diagnostics14030326.
Tan T, Jampol L, Ferris F, Tadayoni R, Sadda S, Chong V Ophthalmol Sci. 2024; 4(3):100449.
PMID: 38313399 PMC: 10837643. DOI: 10.1016/j.xops.2023.100449.